Delayed hemolytic transfusion reaction in sickle cell disease

American Journal of the Medical Sciences

Volumn 312, Issue 4, 1996, Pages 175-181

  Syed, Samira K ^a   Sears, David A ^a,c   Werch, Jochewed B ^a   Udden, Mark M ^a   Milam, John D ^b  

^a BEN TAUB GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alloimmunization; Delayed hemolytic transfusion reaction; Exchange transfusion; Sickle cell disease; Transfusion

Indexed keywords

ADULT; ALLOIMMUNIZATION; ANTIGEN RECOGNITION; ARTICLE; BLOOD TRANSFUSION REACTION; CASE REPORT; ERYTHROCYTE; FEMALE; HEMOLYSIS; HUMAN; PHENOTYPE; SICKLE CELL ANEMIA; BLOOD; BLOOD GROUP TYPING; ERYTHROCYTE TRANSFUSION; IMMUNOLOGY; MALE;

ALLOANTIBODY;

ADULT; ANEMIA, SICKLE CELL; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; ISOANTIBODIES; MALE;

EID: 0030266570     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199610000-00005     Document Type: Article

References (51)

1. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood. 1993;81:1109-23.
2. Diamond WJ, Brown FL Jr, Bittermen P, Klein HG, Davey RJ, Winslow RM. Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. Ann Intern Med. 1980;93: 231-33.
3. Davies SC, McWilliam AC, Hewitt PE, Devenish A, Barozovic M. Red cell alloimmunization in sickle cell disease. Brit J Haematol. 1986;63:241-45.
4. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med. 1988;148: 2485-89.
5. Solanki D, McCurdy PR. Delayed hemolytic transfusion reactions. An often-missed entity. JAMA. 1978;239:729-31.
6. Reeves WB, Ballas SK. Delayed hemolytic transfusion reaction in sickle cell anemia. Transfusion. 1980;20:477.
7. Brumfield CG, Huddleston JF, DuBois LB, Harris BA Jr. A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: A case report and review of the literature. Obstet Gynecol. 1984;63:13S-15S.
8. Milner PF, Squires JE, Larison PJ, Charles WT, Krauss JS. Posttransfusion crises in sickle cell anemia: Role of delayed hemolytic reactions to transfusion. South Med J. 1985;78:1462-69.
9. Rao KRP, Patel AR. Delayed hemolytic transfusion reactions in sickle cell anemia. South Med J. 1989;82:1034-36.
10. Orlina AR, Sosler SD, Koshy M. Problems of chronic transfusion in sickle cell disease. J Clin Apheresis. 1991;6:234-40.
11. Cummins D, Webb G, Shah N, Davies SC. Delayed haemolytic transfusion reactions in patients with sickle cell disease. Postgrad Med J. 1991;67:689-91.
12. Alperin JB, Riglin H, Branch DR, Gallagher MT, Petz LD. Anti-M causing delayed hemolytic transfusion reaction. Transfusion. 1983;23:322-24.
13. Rippee C, Myers J, Gindy L. Blood Groups. In: Petz LD, Swisher SN; eds. Clinical Practice of Transfusion Medicine. 2nd ed. New York: Churchill Livingstone; 1989;82.
14. Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. New Eng J Med. 1988;319:1447-52.
15. Koshy M, Burd L. Management of pregnancy in sickle cell syndromes. Hematol Oncol Clin North Am. 1991;5:585-96.
16. Ambruso DR, Githens JH, Alcorn R, Dixon DJ, Brown LJ, Vaughn WM, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion. 1987;27:94-98.
17. Fudenberg H, Allen FH Jr. Transfusion reactions in the absence of demonstrable incompatibility. New Eng J Med. 1957;256: 1180-84.
18. Ramsey G, Larson P. Loss of red cell alloantibodies over time. Transfusion. 1988;28:162-65.
19. Joseph JI, Awer E, Laulicht M, Scudder J. Delayed hemolytic transfusion reaction due to appearance of multiple antibodies following transfusion of apparently compatible blood. Transfusion. 1964;4:367-71.
20. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 9th ed. Oxford: Blackwell; 1993;104-05.
21. Croucher BEE, Crookston MC, Crookston JH. Delayed haemolytic transfusion reactions stimulating auto-immune haemolytic anemia. Vox Sang. 1967;12:32-42.
22. Pineda AA, Taswell HF, Barzica SM Jr. Delayed hemolytic transfusion reaction. An immunologic hazard of blood transfusion. Transfusion. 1978;18:1-7.
23. Moore, SB, Taswell HF, Pineda AA, Sonnenberg CL. Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test. Am J Clin Pathol. 1980;74:94-97.
24. Hewitt PE, Macintyre EA, Devenish A, Bowcock SJ, Coontreras M. A prospective study of the incidence of delayed haemolytic transfusion reactions following peri-operative blood transfusion. Brit J Haematol. 1988;69:541-44.
25. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: Incidence, long-term serologic findings, and clinical significance. Transfusion. 1990;30:688-93.
26. Vamvakas EC, Pineda, AA, Reisner R, Santrach PJ, Moore SB. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: Incidence and predictors of hemolysis. Transfusion. 1995;35:26-32.
27. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell; 1993; 524-35.
28. Davis KG, Abbott RL. Delayed haemolytic transfusion reactions. Review of three cases. Med J Aust. 1982;1:335-37.
29. Orlina AR, Unger PJ, Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. Amer J Hematol. 1978;5:101-06.
30. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patient populations. Transfusion. 1981;21:462-66.
31. Rosse WF, Gallagher D, Kinney TR, Castro O, Dosik H, Moohr J, et al. Transfusion and alloimmunization in sickle cell disease. Blood. 1990;76:1431-37.
32. Vichinsky EP, Earles A, Johnson RA, Hoag S, Williams, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New Eng J Med. 1990;322:1617-21.
33. Tahhan HR, Holbrook CT, Braddy LR, Brewer LD, Christie JD. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion. 1994;34:562-69.
34. Sarnaik S, Schornack J, Lusher JM. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion. 1986;26:249-52.
35. Reisner EG, Kostyu DD, Phillips G, Walker C, Dawson DV. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens. 1987;30:161-66.
36. Sosler SD, Jilly B, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Transfusion. 1989;29(suppl):69S.
37. Patten E, Patel SN, Soto B, Gayle RA. Transfusion management of patients with sickle cell disease. Ann N Y Acad Sci. 1989;565:446-48.
38. Beattie KM, Shafer AW. Blood center initiatives and role in sickle cell disease. Ann N Y Acad Sci. 1989;565:367-68.
39. o(D)? Vox Sang. 1984;47:205-08.
40. Charache S. Problems in transfusion therapy (editorial). New Eng J Med. 1990;322:1666-68.
41. Mallory D, Malamut D, Ginther A. Rare blood for patients with sickle cell anemia. Ann N Y Acad Sci. 1989;565: 432-33.
42. Ness PM. To match or not to match: the question for chronically transfused patients with sickle cell anemia (editorial). Transfusion. 1994;34:558-60.
43. Chaplin H Jr, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med. 1981;141: 1091-93.
44. Salama A, Mueller-Eckhardt C. Delayed hemolytic transfusion reactions. Evidence for complement activation involving allogeneic and autologous red cells. Transfusion. 1984;24:188-93.
45. Sosler SD, Perkins JT, Saporito C, Unger P, Koshy M. Severe autoimmune hemolytic anemia induced by transfusion in two alloimmunized patients with sickle cell disease. Transfusion. 1989;29(suppl):49S.
46. Lankiewicz MW, Shirey RS, Ness PM, Charache S. Delayed hemolytic transfusion reactions (DHTR) in sickle cell disease (SCD): Evidence for autologous RBC destruction. Transfusion. 1993;33(suppl):22S.
47. Chaplin H Jr. The implication of red cell-bound complement in delayed hemolytic transfusion reactions (editorial). Transfusion. 1984;24:185-87.
48. Pearlman ES, Ballas SK. When to transfuse blood in sickle cell disease? Lessons from Jehovah's Witnesses. Ann Clin Lab Sci. 1994;24:396-400.
49. Vichinsky EP, Haberkern CM, Neumayr L, Earles, AN, Black D, Koshy M, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. New Eng J Med. 1995;333:206-13.
50. Beattie KM, Shafer AW. Broadening the base of a rare donor program by targeting minority populations. Transfusion. 1986;26: 401-04.
51. Mallory D, Malamut D, Sandler SG. A decade of rare donor services in the United States. Report of the American Red Cross Rare Donor Registry (1981-1990). Vox Sang. 1992;63:186-91.